|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1328 | ED149468 | General Research Use | No | Female | White | 58 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1361 | ED148167 | General Research Use | No | Female | White | 73 | 5 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1750 | ED148986 | General Research Use | No | Female | White | 77 | 5 - AREDS AMD Severity Scale Step 3 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2653 | ED149218 | General Research Use | No | Female | White | 72 | 5 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2723 | ED148362 | General Research Use | No | Female | White | 70 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_3115 | ED148526 | General Research Use | No | Female | White | 79 | 5 - AREDS AMD Severity Scale Step 4 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3401 | ED148314 | General Research Use | No | Female | White | 70 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3660 | ED149711 | General Research Use | No | Male | White | 63 | 5 - AREDS AMD Severity Scale Step 4 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0262 | ED149872 | General Research Use | No | Male | White | 73 | 5 - AREDS AMD Severity Scale Step 4 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_0399 | ED149461 | General Research Use | No | Female | White | 71 | 5 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0630 | ED149206 | General Research Use | No | Male | White | 56 | 5 - AREDS AMD Severity Scale Step 4 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0756 | ED150009 | General Research Use | No | Male | White | 69 | 5 - AREDS AMD Severity Scale Step 5 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1755 | ED148782 | General Research Use | No | Female | White | 60 | 5 - AREDS AMD Severity Scale Step 2 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_1784 | ED148420 | General Research Use | No | Female | White | 73 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_2914 | ED148762 | General Research Use | No | Male | White | 78 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3169 | ED149081 | General Research Use | No | Female | White | 76 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0829 | ED150010 | General Research Use | No | Male | White | 75 | 5 - AREDS AMD Severity Scale Step 5 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_1357 | ED150008 | General Research Use | No | Female | White | 51 | 5 - AREDS AMD Severity Scale Step 5 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_0064 | ED149777 | General Research Use | No | Female | White | 70 | 5 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0365 | ED149387 | General Research Use | No | Female | White | 71 | 5 - AREDS AMD Severity Scale Step 1 | 3 - AREDS AMD Severity Scale Step 3 |